2025-01-18 10:06:26
Henlius' Phase 3 clinical study of novel PD-1 inhibitor serplulimab for the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC) meets primary study endpoint
Corporate/ 2023-07-23
Henlius' Phase 3 clinical study of ...

SHANGHAI,Dec. 8,2021-- Shanghai Henlius Biotech,Inc. (2696.HK) announced that the first interim analysis met the primary study endpoint of t...

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
Corporate/ 2023-07-23
Venus Medtech Acquires Cardiovalve to Op...

HANGZHOU,China,Dec. 8,2021-- Venus Medtech (Hangzhou) Inc. (Venus MedTech,2500.HK),a leading,innovative Chinese structural heart disease tre...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release